ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ULTRAVATE
Topical steroids
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ULTRAVATE Rx

Generic Name and Formulations:
Halobetasol propionate 0.05%; crm; oint.

Company:
Sun Pharmaceutical Industries

Therapeutic Use:

Indications for ULTRAVATE:

Corticosteroid-responsive dermatoses.

Adult:

Apply a thin layer to affected areas 1–2 times daily; max 50 g/week and 2 consecutive weeks' treatment per course. Discontinue when control is achieved. Do not occlude.

Children:

Not recommended.

Warnings/Precautions:

Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis, rosacea, perioral dermatitis, or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Adverse Reactions:

Burning, stinging, itching, dry skin, erythema, skin atrophy, leukoderma, vesicles, rash, pustulation, acne, secondary infections, telangiectasia, urticaria, miliaria; HPA axis suppression (esp. in children).

How Supplied:

Crm, oint—50g

Sign Up for Free e-Newsletters



CME Focus